Similar articles

• Rosuvastatin in patients undergoing hemodialysis.

  Kassimatis TI, Konstantinopoulos PA. Kassimatis TI, et al. N Engl J Med. 2009 Jul 2;361(1):93; author reply 94-5. N Engl J Med. 2009. PMID: 19579277 No abstract available.
• Rosuvastatin in patients undergoing hemodialysis.

  de Oliveira JM. de Oliveira JM. N Engl J Med. 2009 Jul 2;361(1):93-4; author reply 94-5. N Engl J Med. 2009. PMID: 19579278 No abstract available.
• Rosuvastatin in patients with elevated C-reactive protein.

  Pierard LA. Pierard LA. N Engl J Med. 2009 Mar 5;360(10):1040; author reply 1041-2. N Engl J Med. 2009. PMID: 19271277 No abstract available.
• The Jupiter study, CRP screening, and aggressive statin therapy-implications for the primary prevention of cardiovascular disease.

  Kones R. Kones R. Ther Adv Cardiovasc Dis. 2009 Aug;3(4):309-15. doi: 10.1177/1753944709337056. Epub 2009 May 21. Ther Adv Cardiovasc Dis. 2009. PMID: 19460829 Review.
• [Lipid lowering by rosuvastatin: how do statins differ?].

  Laufs U. Laufs U. Dtsch Med Wochenschr. 2015 Mar;140(5):313. doi: 10.1055/s-0041-100713. Epub 2015 Mar 3. Dtsch Med Wochenschr. 2015. PMID: 25734669 Review. German. No abstract available.